Data spanning the past 90 days through February 19, 2026 reveals that UroGen Pharma's three principal insider shareholders consist of Director Ran Nussbaum (1.48Mn shares), Director Arie Belldegrun (408.69K shares), Chief Executive Officer Elizabeth A. Barrett (326.69K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Ran Nussbaum | 1,481,927 | 25 Oct, 2022 | |
| Arie Belldegrun | 408,693 | 16 Sep, 2022 | |
| Elizabeth A. Barrett | Chief Executive Officer | 326,691 | 02 Feb, 2023 |
| Mark Schoenberg | Chief Medical Officer | 144,985 | 04 Feb, 2026 |
| Fred E Cohen | 69,339 | 28 Jul, 2023 | |
| Jason Drew Smith | General Counsel | 55,588 | 11 Feb, 2026 |
| Dong Kim | Chief Financial Officer | 37,753 | 12 Sep, 2024 |
| Molly Henderson | Chief Financial Officer | 5,248 | 02 Feb, 2022 |
| Chris Degnan | Chief Financial Officer | 2,280 | 09 Oct, 2025 |
| Daniel George Wildman | 2,000 | 01 Dec, 2025 | |
| James A. Jr. Robinson | 2,000 | 01 Dec, 2025 | |
| Stuart Holden | 2,000 | 01 Dec, 2025 | |
| Leana Wen | 2,000 | 01 Dec, 2025 | |
| Cynthia M Butitta | 2,000 | 01 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Feb, 2026 | Mark Schoenberg | Ordinary Shares | D | 3,686 | $19.69 | 144,985 | D | S |
| 03 Feb, 2026 | Mark Schoenberg | Ordinary Shares | D | 1,843 | $19.69 | 148,671 | D | S |
| 03 Feb, 2026 | Mark Schoenberg | Ordinary Shares | D | 1,844 | $19.69 | 150,514 | D | S |
| 03 Feb, 2026 | Jason Drew Smith | Ordinary Shares | D | 2,654 | $19.69 | 52,934 | D | S |
| 03 Feb, 2026 | Jason Drew Smith | Ordinary Shares | D | 3,217 | $19.69 | 55,588 | D | S |
| 03 Feb, 2026 | Jason Drew Smith | Ordinary Shares | D | 1,608 | $19.69 | 51,326 | D | S |
| 31 Jan, 2026 | Mark Schoenberg | Ordinary Shares | A | 6,666 | - | 152,358 | D | M |
| 31 Jan, 2026 | Mark Schoenberg | Ordinary Shares | A | 3,333 | - | 145,692 | D | M |
| 31 Jan, 2026 | Mark Schoenberg | Ordinary Shares | A | 3,334 | - | 142,359 | D | M |
| 31 Jan, 2026 | Jason Drew Smith | Ordinary Shares | A | 3,333 | - | 58,805 | D | M |
| 31 Jan, 2026 | Jason Drew Smith | Ordinary Shares | A | 6,667 | - | 49,972 | D | M |
| 31 Jan, 2026 | Jason Drew Smith | Ordinary Shares | A | 5,500 | - | 55,472 | D | M |
| 26 Nov, 2025 | Cynthia M Butitta | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | Cynthia M Butitta | - | - | 2,000 | D | |||
| 26 Nov, 2025 | James A. Jr. Robinson | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | Stuart Holden | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | Leana Wen | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 26 Nov, 2025 | Daniel George Wildman | ordinary shares | A | 2,000 | - | 2,000 | D | M |
| 19 Nov, 2025 | Mark Schoenberg | Ordinary Shares | D | 10,000 | $25.00 | 139,025 | D | S |
| 08 Oct, 2025 | Chris Degnan | - | - | 2,280 | D |